Resveratrol attenuates monocyte-to-macrophage differentiation and associated inflammation via modulation of intracellular GSH homeostasis: Relevance in atherosclerosis

Free Radical Biology and Medicine

Volumn 96, Issue , 2016, Pages 392-405

  Vasamsetti, Sathish Babu ^a,b   Karnewar, Santosh ^a,b   Gopoju, Raja ^a,b   Gollavilli, Paradesi Naidu ^a,b   Narra, Sai Ram ^c   Kumar, Jerald Mahesh ^c   Kotamraju, Srigiridhar ^a,b  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH   (India)

^c CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

AMPK; Atherosclerosis; GSH; Inflammation; Monocyte differentiation; Resveratrol

Indexed keywords

ACETYLCYSTEINE; ANGIOTENSIN II; APOLIPOPROTEIN E; BUTHIONINE SULFOXIMINE; GELATINASE B; GLUTATHIONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERLEUKIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PHORBOL 13 ACETATE 12 MYRISTATE; RESVERATROL; SCAVENGER RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; AMPK ALPHA1 SUBUNIT, MOUSE; ANTIOXIDANT; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL ADHESION; CELL DIFFERENTIATION; CELL SIZE; CONTROLLED STUDY; DISEASE EXACERBATION; DOSE RESPONSE; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; HOMEOSTASIS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ACETYLCYSTEINE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTIOXIDANTS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BUTHIONINE SULFOXIMINE; CELL DIFFERENTIATION; GLUTATHIONE; HOMEOSTASIS; HUMANS; INFLAMMATION; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; MONOCYTES; STILBENES; TETRADECANOYLPHORBOL ACETATE;

EID: 84968813268     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2016.05.003     Document Type: Article

References (49)

1. A.J. Lusis Atherosclerosis Nature 407 2000 233 241
2. K.J. Williams, I. Tabas, Atherosclerosis - an inflammatory disease, N. Engl. J. Med. 340, 1928; Author Reply 1929; 1999.
3. K.J. Moore, and I. Tabas Macrophages in the pathogenesis of atherosclerosis Cell 145 2011 341 355
4. S. Gordon, and P.R. Taylor Monocyte and macrophage heterogeneity Nat. Rev. Immunol. 5 2005 953 964
5. P. Libby, P.M. Ridker, and G.K. Hansson Progress and challenges in translating the biology of atherosclerosis Nature 473 2011 317 325
6. J.B. Michel, Z. Li, and P. Lacolley Smooth muscle cells and vascular diseases Cardiovasc. Res. 95 2012 135 137
7. S.B. Vasamsetti, S. Karnewar, A.K. Kanugula, A.R. Thatipalli, J.M. Kumar, and S. Kotamraju Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis Diabetes 64 2015 2028 2041
8. J.A. Baur, and D.A. Sinclair Therapeutic potential of resveratrol: the in vivo evidence Nat. Rev. Drug Discov. 5 2006 493 506
9. L.M. Hung, J.K. Chen, S.S. Huang, R.S. Lee, and M.J. Su Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes Cardiovasc. Res. 47 2000 549 555
10. R. Miatello, M. Vazquez, N. Renna, M. Cruzado, A.P. Zumino, and N. Risler Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats Am. J. Hypertens. 18 2005 864 870
11. S. Renaud, and M. de Lorgeril Wine, alcohol, platelets, and the French paradox for coronary heart disease Lancet 339 1992 1523 1526
12. B. Catalgol, S. Batirel, Y. Taga, and N.K. Ozer Resveratrol: French paradox revisited Front. Pharmacol. 3 2012 141
13. K. Magyar, R. Halmosi, A. Palfi, G. Feher, L. Czopf, A. Fulop, I. Battyany, B. Sumegi, K. Toth, and E. Szabados Cardioprotection by resveratrol: a human clinical trial in patients with stable coronary artery disease Clin. Hemorheol. Microcirc. 50 2012 179 187
14. D.M. Breen, V.W. Dolinsky, H. Zhang, H. Ghanim, J. Guo, M. Mroziewicz, E.L. Tsiani, M.P. Bendeck, P. Dandona, J.R. Dyck, S.P. Heximer, and A. Giacca Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism Atherosclerosis 222 2012 375 381
15. S.M. Jeon, S.A. Lee, and M.S. Choi Antiobesity and vasoprotective effects of resveratrol in apoE-deficient mice J. Med. Food 17 2014 310 316
16. B. Poussier, A.C. Cordova, J.P. Becquemin, and B.E. Sumpio Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis J. Vasc. Surg. 42 2005 1190 1197
17. L. Fremont, L. Belguendouz, and S. Delpal Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids Life Sci. 64 1999 2511 2521
18. J. Tome-Carneiro, M. Gonzalvez, M. Larrosa, M.J. Yanez-Gascon, F.J. Garcia-Almagro, J.A. Ruiz-Ros, F.A. Tomas-Barberan, M.T. Garcia-Conesa, and J.C. Espin Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease. Cardiovascular drugs and therapy/sponsored by the International Society of Cardiovascular Pharmacotherapy 27 2013 37 48
19. S. Khurana, K. Venkataraman, A. Hollingsworth, M. Piche, and T.C. Tai Polyphenols: benefits to the cardiovascular system in health and in aging Nutrients 5 2013 3779 3827
20. N. Ballatori, S.M. Krance, S. Notenboom, S. Shi, K. Tieu, and C.L. Hammond Glutathione dysregulation and the etiology and progression of human diseases Biol. Chem. 390 2009 191 214
21. K. Kugiyama, Y. Miyao, T. Sakamoto, H. Kawano, H. Soejima, S. Miyamoto, M. Yoshimura, H. Ogawa, S. Sugiyama, and H. Yasue Glutathione attenuates coronary constriction to acetylcholine in patients with coronary spastic angina Am. J. Physiol. Heart Circ. Physiol. 280 2001 H264 H271
22. A. Prasad, N.P. Andrews, F.A. Padder, M. Husain, and A.A. Quyyumi Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability J. Am. Coll. Cardiol. 34 1999 507 514
23. Y.J. Huh, J.M. Kim, H. Kim, H. Song, H. So, S.Y. Lee, S.B. Kwon, H.J. Kim, H.H. Kim, S.H. Lee, Y. Choi, S.C. Chung, D.W. Jeong, and B.M. Min Regulation of osteoclast differentiation by the redox-dependent modulation of nuclear import of transcription factors Cell Death Differ. 13 2006 1138 1146
24. M. Daigneault, J.A. Preston, H.M. Marriott, M.K. Whyte, and D.H. Dockrell The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages PloS One 5 2010 e8668
25. P.J. Hissin, and R. Hilf A fluorometric method for determination of oxidized and reduced glutathione in tissues Anal. Biochem. 74 1976 214 226
26. J. Bai, and A.I. Cederbaum Overexpression of CYP2E1 in mitochondria sensitizes HepG2 cells to the toxicity caused by depletion of glutathione J. Biol. Chem. 281 2006 5128 5136
27. A. Daugherty, M.W. Manning, and L.A. Cassis Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice J. Clin. Investig. 105 2000 1605 1612
28. J. Mahesh Kumar, P.L. Reddy, V. Aparna, G. Srinivas, P. Nagarajan, R. Venkatesan, C. Sreekumar, and B. Sesikaran Strobilocercus fasciolaris infection with hepatic sarcoma and gastroenteropathy in a Wistar colony Vet. Parasitol. 141 2006 362 367
29. H. Sakamoto, M. Aikawa, C.C. Hill, D. Weiss, W.R. Taylor, P. Libby, and R.T. Lee Biomechanical strain induces class a scavenger receptor expression in human monocyte/macrophages and THP-1 cells: a potential mechanism of increased atherosclerosis in hypertension Circulation 104 2001 109 114
30. H. Kim, I.Y. Kim, S.Y. Lee, and D. Jeong Bimodal actions of reactive oxygen species in the differentiation and bone-resorbing functions of osteoclasts FEBS Lett. 580 2006 5661 5665
31. P. Calzadilla, D. Sapochnik, S. Cosentino, V. Diz, L. Dicelio, J.C. Calvo, and L.N. Guerra N-acetylcysteine reduces markers of differentiation in 3T3-L1 adipocytes Int. J. Mol. Sci. 12 2011 6936 6951
32. P. Lacolley, V. Regnault, A. Nicoletti, Z. Li, and J.B. Michel The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles Cardiovasc. Res. 95 2012 194 204
33. H. Capiralla, V. Vingtdeux, H. Zhao, R. Sankowski, Y. Al-Abed, P. Davies, and P. Marambaud Resveratrol mitigates lipopolysaccharide- and Abeta-mediated microglial inflammation by inhibiting the TLR4/NF-kappaB/STAT signaling cascade J. Neurochem. 120 2012 461 472
34. Z. Liu, C. Jiang, J. Zhang, B. Liu, and Q. Du Resveratrol inhibits inflammation and ameliorates insulin resistant endothelial dysfunction via regulation of AMP-activated protein kinase and sirtuin 1 activities J. Diabetes 2015
35. R.L. Tiwari, V. Singh, A. Singh, M. Rana, A. Verma, N. Kothari, M. Kohli, J. Bogra, M. Dikshit, and M.K. Barthwal PKCdelta-IRAK1 axis regulates oxidized LDL-induced IL-1beta production in monocytes J. Lipid Res. 55 2014 1226 1244
36. S.K. Jain, and D. Micinski Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes Biochem. Biophys. Res. Commun. 437 2013 7 11
37. H. Zhang, A. Shih, A. Rinna, and H.J. Forman Resveratrol and 4-hydroxynonenal act in concert to increase glutamate cysteine ligase expression and glutathione in human bronchial epithelial cells Arch. Biochem. Biophys. 481 2009 110 115
38. P.M. Brito, A. Mariano, L.M. Almeida, and T.C. Dinis Resveratrol affords protection against peroxynitrite-mediated endothelial cell death: a role for intracellular glutathione Chemico-Biol. Interact. 164 2006 157 166
39. Z. Cao, and Y. Li Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury Eur. J. Pharmacol. 489 2004 39 48
40. Y. Li, Z. Cao, and H. Zhu Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress Pharmacol. Res. 53 2006 6 15
41. J.M. Lean, J.T. Davies, K. Fuller, C.J. Jagger, B. Kirstein, G.A. Partington, Z.L. Urry, and T.J. Chambers A crucial role for thiol antioxidants in estrogen-deficiency bone loss J. Clin. Investig. 112 2003 915 923
42. P. Vigilanza, K. Aquilano, S. Baldelli, G. Rotilio, and M.R. Ciriolo Modulation of intracellular glutathione affects adipogenesis in 3T3-L1 cells J. Cell. Physiol. 226 2011 2016 2024
43. X. Yang, H. Yao, Y. Chen, L. Sun, Y. Li, X. Ma, S. Duan, X. Li, R. Xiang, J. Han, and Y. Duan Inhibition of glutathione production induces macrophage CD36 expression and enhances cellular-oxidized low density lipoprotein (oxLDL) uptake J. Biol. Chem. 290 2015 21788 21799
44. M. Rosenblat, R. Coleman, and M. Aviram Increased macrophage glutathione content reduces cell-mediated oxidation of LDL and atherosclerosis in apolipoprotein E-deficient mice Atherosclerosis 163 2002 17 28
45. B.B. Zhang, G. Zhou, and C. Li AMPK: an emerging drug target for diabetes and the metabolic syndrome Cell Metab. 9 2009 407 416
46. H. Kanamori, G. Takemura, K. Goto, A. Tsujimoto, A. Ogino, T. Takeyama, T. Kawaguchi, T. Watanabe, K. Morishita, M. Kawasaki, A. Mikami, T. Fujiwara, H. Fujiwara, M. Seishima, and S. Minatoguchi Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway Am. J. Pathol. 182 2013 701 713
47. N. Nagai, S. Kubota, K. Tsubota, and Y. Ozawa Resveratrol prevents the development of choroidal neovascularization by modulating AMP-activated protein kinase in macrophages and other cell types J. Nutr. Biochem. 25 2014 1218 1225
48. X.S. Gu, Z.B. Wang, Z. Ye, J.P. Lei, L. Li, D.F. Su, and X. Zheng Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure Genet. Mol. Res. 13 2014 323 335
49. R. Guo, B. Liu, K. Wang, S. Zhou, W. Li, and Y. Xu Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in Db/Db mice by inhibiting the NF-kappaB pathway Diabetes Vasc. Dis. Res. 11 2014 92 102